Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

33 results about "Ciliary sulcus" patented technology

Ciliary sulcus fixation is the best second alternative site for fixation of the IOL in the presence of available capsular support. 3, 5, 8, 9, 10, 12, 13 Several case series have been reported, indicating that a lens placed in the ciliary sulcus is reasonably safe and effective over the short term.

Accommodating Intraocular Lens Assemblies and Accommodation Measurement Implant

InactiveUS20080004699A1Accurate eyesight correctionIntraocular lensMedicineHuman eye
The present invention pertains to accommodating intraocular lens (AIOL) assemblies including a haptics system for self-anchoring implantation in a human eye's annular ciliary sulcus for retaining an AIOL at a desired position along the human eye's visual axis, and an accommodation measurement implant (AMI) for determining accommodation and accommodation forces in an experimental set-up including an animal's eye.
Owner:FORSIGHT VISION5 INC

Intraocular lens insertion device

An intraocular lens insertion device comprises a pad formed by an elastic element harmless to a living body, a drawing thread mounted on a rear portion of the pad, and an insert portion formed at a front portion of the pad. The insert portion has a shape suitable to fit into a ciliary sulcus of an aphakic eye. The pad has a thickness capable of covering a tip end of a surgical needle.
Owner:SUGIURA TAKESHI

Ciliary sulcus positioner

The ciliary sulcus positioner comprises a guide tube which is of a straight tube structure, and a puncture needle is arranged in the guide tube in a penetrating mode; the guide tube is provided with a front end serving as an insertion end and a rear end opposite to the front end; the front end is provided with a front end opening for the puncture needle to penetrate out, and the rear end is provided with a rear end opening for the puncture needle to penetrate in; scale marks are further arranged on the tube wall of the guide tube. The pointer is connected with the guide tube and moves together with the guide tube; the pointer is provided with an indicating end adjacent to the front end of the guide tube; the indicating end is provided with a light emitting part which can be controlled to emit light; the distance between the indicating end of the indicating pointer and the front end is 1-5 mm. The whole pointer and the guide tube extend forwards together, and the indicating end of the pointer and the front end of the guide tube are spaced to form a spacing opening for clamping an iris between the pointer and the guide tube.
Owner:王素常

Posterior chamber phakic intraocular lens

PendingCN112566589AImprove axialImprove stabilityIntraocular lensPosterior chamber phakic intraocular lensOptometry
The invention relates to a posterior chamber phakic intraocular lens (1) comprising a central optical part (2), a peripheral haptic part (3) comprising a plurality of support elements (4A-D) arrangedto lie on a ciliary zonule of an eye, and a plurality of flexible elongated haptics (5A-D) arranged to hook into a ciliary sulcus of the eye.
Owner:PHYSIOL

Posterior chamber phakic intraocular lens

PendingCN113873969AIntraocular lensOphthalmologyPosterior chamber phakic intraocular lens
The present invention relates to a posterior chamber phakic intraocular lens (1) comprising a central optical part (2), a peripheral haptic part (3) comprising a plurality of support elements (4A-D) arranged to lie on a ciliary zonule of an eye, and at least one flexible haptic (5) comprising a reticulated distal region (52) arranged to lay into a ciliary sulcus of the eye.
Owner:PHYSIOL

Intraocular drug delivery device and associated methods

Devices, systems, and methods for delivery of an active agent from the lens capsule to a posterior segment of the eye of a subject can include an intraocular active agent delivery device including anactive agent dispersed within a biodegradable active agent matrix. The active agent includes dexamethasone and the delivery device is adapted to fit within a lens capsule or ciliary sulcus of an eye.The delivery device can be inserted into the lens capsule or ciliary sulcus of an eye during cataract surgery or for treatment of uveitis.
Owner:UNIV OF UTAH RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products